Berkshire Hathaway Roughly Tripled $10,000 in a Decade. Did It Beat the Market?

Berkshire Hathaway’s $10,000 investment from Aug. 25, 2016 grew to about $33,900 by Aug. 25, 2026, versus about $41,300 for an S&P 500 index fund with dividends reinvested (roughly $7,400 ahead). The company’s operating earnings rose from $17.6B (2016) to $44.5B (2025), but operating earnings slipped in 2025 from $47.4B and the stock now trades around ~21x annualized Q2 operating earnings (about 6% below its $537.74 52-week high) after repurchasing ~$4.5B shares in the quarter. Despite solid business momentum (Q2 operating earnings +16% YoY), the article argues valuation is less attractive than earlier in the decade and that Berkshire’s return has lagged the AI-driven index.

Analysis

Berkshire now looks less like a special situation and more like a high-quality, low-beta compounding machine priced as such. The key variable is not headline earnings volatility but the pace of deployable capital: if float growth and buybacks slow while cash remains under-earning, per-share compounding decelerates and the multiple becomes harder to defend. That makes BRK.B a much better business than a cheap stock, which is a subtle but important distinction for forward returns.

Relative to the market, the bigger message is regime dependence. In an AI-led tape, Berkshire’s mix has little embedded operating leverage, so it will usually lag the index when mega-cap growth carries multiples higher; in a breadth rotation or risk-off environment, it becomes one of the cleaner shelters because its balance sheet and insurance float provide internal financing that cyclicals and levered financials do not have. The second-order winner here is not another conglomerate, but any defensive equity proxy with durable cash generation and limited capex intensity.

The contrarian risk on the other side is that consensus may still treat Berkshire as a perpetual compounding bargain, when in reality the easy multiple expansion phase is likely over. The main falsifiers are either a material pickup in buyback pace or a sustained acceleration in underwriting/investment income that lifts per-share growth above the market’s hurdle; absent that, the stock can compound, but likely not fast enough to outrun broad-market leadership for long. Time horizon matters: this is a months-to-years valuation call, not a next-week catalyst trade.

Key Decisions for Investors

• Do not chase BRK.B here; wait for a 7-10% pullback or evidence of materially higher buyback intensity before adding. Risk/reward is muted at a mid-cycle multiple unless per-share growth re-accelerates.
• Pair trade for a 6-12 month horizon: long BRK.B / short SPY as a defensive hedge if you expect AI breadth to narrow or mega-cap multiple expansion to cool. Target modest spread outperformance rather than absolute alpha; stop if SPY leadership broadens and earnings revisions keep improving.
• For existing BRK.B holders, consider covered calls 3-6 months out about 5% OTM to monetize limited near-term upside. This is a better risk-adjusted expression than adding outright at current valuation.
• Watch item: if Berkshire buybacks stay below roughly $5B per quarter for another 2 quarters, treat that as a warning that management sees shares as fairly valued and the compounding engine is cooling. That would argue for reducing exposure.
• If you want a cleaner defensive rotation, compare BRK.B vs XLF on a relative basis; BRK.B deserves a premium to levered financials, but not if financials re-rate on lower rates and stronger loan growth.